CN Patent

CN114144169A — 醋酸亮丙瑞林组合物和使用其治疗乳腺癌的方法

Assigned to Tolmar International Ltd · Expires 2022-03-04 · 4y expired

What this patent protects

用于抑制具有激素受体阳性乳腺癌的患者中的卵巢功能的组合物和方法。

USPTO Abstract

用于抑制具有激素受体阳性乳腺癌的患者中的卵巢功能的组合物和方法。

Drugs covered by this patent

leuprolide-mesylate (LEUPROLIDE MESYLATE)

Patent Metadata

Patent number: CN114144169A
Jurisdiction: CN
Classification: —
Expires: 2022-03-04
Drug substance claim: No
Drug product claim: No
Assignee: Tolmar International Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.